Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene

被引:10
作者
Cecena, G
Wen, F
Cardiff, RD
Oshima, RG
机构
[1] Burnham Inst, Oncodev Biol Program, Canc Res Ctr, La Jolla, CA 92037 USA
[2] Univ Calif Davis, Ctr Comparat Med, Dept Pathol, Davis, CA 95616 USA
关键词
D O I
10.2353/ajpath.2006.050443
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
To determine how different epithelial cell types respond to the same oncogenic stimulation, we have used a modified human keratin 18 gene to conditionally express the polyomavirus middle T antigen (PyMT) oncogene in simple epithelial tissues of transgenic mice. Activation of PyMT expression by transgenic Cre recombinase in mammary epithelial cells resulted in carcinomas in all bitransgenic females. PyMT expression induced by K18-driven Cre in internal epithelial organs resulted in pancreatic acinar metaplasia and ductal dysplasia with remarkable desmoplastic stromal responses in all 25 bitransgenic mice. Hepatoma formation with altered lipid metabolism and gastric adenocarcinoma occurred in 96 and 54% of these mice, respectively. Elevated PyMT RNA expression also correlated with intraepithelial neoplasia in the prostate. Activated Erk2 was found in mammary tumors, pancreatic tissues, and affected livers. Hes1 RNA, a target of Notch signaling that has been implicated downstream of Ras pathway activation, was elevated in pancreatic and liver lesions. The variety of responses of different epithelia to PyMT demonstrates the importance of the differentiated state in interpreting oncogenic signals.
引用
收藏
页码:310 / 320
页数:11
相关论文
共 39 条
[1]   A SINGLE HUMAN KERATIN-18 GENE IS EXPRESSED IN DIVERSE EPITHELIAL-CELLS OF TRANSGENIC MICE [J].
ABE, M ;
OSHIMA, RG .
JOURNAL OF CELL BIOLOGY, 1990, 111 (03) :1197-1206
[2]   Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma [J].
Aguirre, AJ ;
Bardeesy, N ;
Sinha, M ;
Lopez, L ;
Tuveson, DA ;
Horner, J ;
Redston, MS ;
DePinho, RA .
GENES & DEVELOPMENT, 2003, 17 (24) :3112-3126
[3]  
AGUZZI A, 1990, New Biologist, V2, P533
[4]   Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis [J].
Andrechek, ER ;
Hardy, WR ;
Siegel, PM ;
Rudnicki, MA ;
Cardiff, RD ;
Muller, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3444-3449
[5]  
Cardiff RD, 2001, MICROSC RES TECHNIQ, V52, P224, DOI 10.1002/1097-0029(20010115)52:2<224::AID-JEMT1007>3.0.CO
[6]  
2-A
[7]  
Cardiff Robert D, 2004, Toxicol Pathol, V32 Suppl 1, P31, DOI 10.1080/01926230490424662
[8]   Signal transduction in mammary tumorigenesis: a transgenic perspective [J].
Dankort, DL ;
Muller, WJ .
ONCOGENE, 2000, 19 (08) :1038-1044
[9]   Initiating oncogenic event determines gene-expression patterns of human breast cancer models [J].
Desai, KV ;
Xiao, N ;
Wang, W ;
Gangi, L ;
Greene, J ;
Powell, JI ;
Dickson, R ;
Furth, P ;
Hunter, K ;
Kucherlapati, R ;
Simon, R ;
Liu, ET ;
Green, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6967-6972
[10]   Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors [J].
Galang, CK ;
Muller, WJ ;
Foos, G ;
Oshima, RG ;
Hauser, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) :11281-11292